DL

Daniel Lin-Arlow

CEO

Ansa Biotechnologies, Inc.

Berkeley, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ansa Biotechnologies, Inc.
Industry
research
Employees
79.0
Seniority
C suite
Annual Revenue
9000000.0
Total Funding
82200000.0
Latest Funding
Series A

Technologies

Cloudflare DNS Gmail Outlook Pardot Google Apps Microsoft Office 365 Google Cloud Hosting Amazon AWS Hubspot Amazon SES Salesforce Nginx Vimeo WordPress.org Google Tag Manager Mobile Friendly Remote Circle

Keywords

dna biotechnology research dna synthesis enzymatic dna synthesis complex dna sequences clonal dna products dna fragments gene therapy crispr genome editing high gc content sequence verification linear double-stranded dna promoters utrs secondary structures repetitive sequences synthetic biology biological research pharmaceuticals healthcare innovation mrna vaccines transgene expression biomanufacturing personalized medicine synthetic nucleic acids biotech partnerships research breakthroughs custom dna synthesis genetic engineering sequence-perfect synthesis genetic material long dna strands high-throughput synthesis sequencing technology biosecurity screening innovative solutions scientific collaboration custom informatics multiplexed sequences downstream processing scientific research clinical applications synthetic genes targeted therapies biotech innovations manufacturing technology early access program research & development rapid synthesis scientific goals advanced applications biotechnology medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans